Management of Elevated ASO Titre in Psoriasis
An elevated ASO titre in a patient with psoriasis indicates a preceding streptococcal infection that may have triggered or exacerbated the psoriasis, and management should focus on treating the psoriasis itself according to standard protocols while considering antibiotic therapy only if active streptococcal infection is documented.
Understanding the ASO-Psoriasis Connection
The relationship between streptococcal infection and psoriasis is well-established, particularly for guttate psoriasis. However, elevated ASO titres are found across all psoriasis subtypes 1. Research shows that 60% of psoriasis patients have positive ASLO tests, including those with plaque psoriasis, guttate psoriasis, palmoplantar pustulosis, and erythroderma 1.
Important Caveats About ASO Interpretation
ASO reflects past, not current infection 2. Elevated titres indicate immunologic events from 1-6 weeks prior, with levels potentially remaining elevated for months after even uncomplicated infections 2.
Non-specific elevation occurs 3. In acute guttate psoriasis, non-immunological reactions with serum lipoproteins can cause falsely elevated ASO at 2-3 weeks after eruption onset, normalizing by 5-6 weeks 3.
Age-dependent normal values: Normal ASO levels are higher in school-age children than adults 2. The upper limit of normal varies by population (210-515 IU/mL in different studies) 4, 5.
Anti-DNase B is more sensitive: When screening for streptococcal infection evidence, anti-DNase B titres are significantly more sensitive than ASO alone 6.
Clinical Management Algorithm
Step 1: Assess for Active Streptococcal Infection
Perform a pharyngeal culture to detect active Group A Streptococcus 7:
If culture is positive for S. pyogenes: Treat with antibiotics per standard protocols 2
- Penicillin V 500 mg 2-3 times daily for 10 days, OR
- Benzathine penicillin G 1,200,000 U intramuscularly once
- For penicillin allergy: Azithromycin 500 mg daily for 5 days
If culture is negative: The elevated ASO represents past infection; antibiotics are not indicated
Step 2: Classify Psoriasis Type and Severity
The psoriasis management approach differs based on presentation 8:
Guttate Psoriasis (especially with documented streptococcal trigger):
- Often responds to antimicrobial treatment when active infection is present 7
- Expect remission within 1 month of appropriate antibiotic therapy 7
- Can be managed in primary care if mild 8
Chronic Plaque Psoriasis:
- Initiate topical therapy regardless of ASO status 8
- Start with coal tar (0.5-1% crude coal tar in petroleum jelly, increasing to maximum 10%) or dithranol (0.1-0.25%, doubling concentration as tolerated) 8
- Topical corticosteroids under controlled conditions: maximum 100g of moderately potent preparation monthly, with regular clinical review and periods using alternative treatments 8
Severe/Unstable Psoriasis (pustular, erythrodermic):
- Requires dermatologist supervision 8
- Consider systemic therapy: methotrexate, cyclosporin, or retinoids 8
Step 3: Monitor Response
For guttate psoriasis with positive culture: Repeat ASO/anti-DNase B at 4-6 weeks to confirm specific (not non-specific) elevation and document response 3
For all types: Clinical response to psoriasis treatment is the primary endpoint, not ASO normalization 9. ASO may remain elevated for months despite clinical remission 9.
Key Clinical Pitfalls to Avoid
Do not treat elevated ASO alone without active infection: ASO elevation does not mandate antibiotic therapy unless active streptococcal infection is documented by culture 2.
Do not delay psoriasis treatment: Standard psoriasis management should proceed regardless of ASO status 8. The elevated titre explains potential trigger but doesn't change treatment approach for chronic plaque disease.
Avoid misinterpreting laboratory values: Ensure your laboratory uses age-appropriate reference ranges 2, 4. Consider anti-DNase B if ASO is borderline 6.
Do not use systemic corticosteroids: These can precipitate erythrodermic or pustular psoriasis upon withdrawal 8. Reserve for only three specific scenarios: persistent uncontrollable erythroderma with metabolic complications, generalized pustular psoriasis when other drugs contraindicated, or hyperacute psoriatic polyarthritis threatening irreversible joint damage 8.
Special Considerations
Drug interactions to avoid 8: Beta-blockers, NSAIDs, lithium, chloroquine, and mepacrine can precipitate or worsen psoriasis—review medication list carefully.
Family history matters 6: Patients with elevated antistreptococcal antibodies more frequently report family history of psoriasis, sudden flares, and early recurrences after treatment.